Research Papers

25 of 87 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn's disease: post hoc analys…
D'Haens G; Baert F; Danese S; Kobayashi T; Loftus EV; Sandborn WJ; Dornic Q; Lindner D; Kisfalvi K; Marins EG; Vermeire S.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection.
Lai X; Chen H; Dong X; Zhou G; Liang D; Xu F; Liu H; Luo Y; Liu H; Wan S.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Management advice for patients with reflux-like symptoms: an evidence-based consensus.
Hungin AP; Yadlapati R; Anastasiou F; Bredenoord AJ; El Serag H; Fracasso P; Mendive JM; Savarino EV; Sifrim D; Udrescu M; Kahrilas PJ.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based stud…
Zhang W; Chen Z; Sa B.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis.
Wang X; Liu H; Wang P; Wang Y; Yi Y; Li X.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Association between novel inflammatory markers and non-alcoholic fatty liver disease: a cross-sectional study.
Wang G; Zhao Y; Li Z; Li D; Zhao F; Hao J; Yang C; Song J; Gu X; Huang R.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A novel risk score model of esophageal stricture for patients undergoing endoscopic submucosal dissection.
Yan J; Yang Z; Gao L; He L; Chen M; Ding H; Shen R; Gong Y; Zhang G.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort…
Sun N; Wang X; Wei J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Registered
Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled t…
Dimachkie R; Hamadi R; Alameddine Z; Aridi H; Sakr F; Asmar S; Deeb L.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
2/6 Transparent
Association of nonalcoholic fatty liver disease with colorectal adenomatous polyps and non-adenomatous polyps: a cross-…
Yang Y; Teng Y; Shi J; Xu J; Bao J; Zhang X; Wang Q.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
1/6 Transparent
Longitudinal surveillance of three biomarkers to predict recurrence of hepatocellular carcinoma after radical resection.
Tong JS; Lu CD; Lu CJ; Zheng S; Mao SQ.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carri…
Ning H; Li K; Peng Z; Jin H; Zhao H; Shang J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Correlation between ABO blood group and prognosis of hepatectomy for hepatitis B virus-associated hepatocellular carcin…
Liao Y; Liang T; He Y; Mo S; Zhao S; Gao Q; Han C; Peng T.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Vaccines - beliefs and concerns: the voice of patients with inflammatory immunomediated diseases.
Abreu C; Martins A; Branco E; Rocha R; Sarmento A; Magro F.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Complications and local recurrence of malignant liver tumor after ablation in risk areas: a retrospective analysis.
Yang D; Yang J; Zhu F; Hui J; Li C; Cheng S; Hu D; Wang J; Han L; Wang H.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia.
Mohamed R; Yip C; Singh S.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Administration of maximum dose of mucolytic solution before upper endoscopy - a double-blind, randomized trial.
Stepan M; Fojtík P; Psar R; Hanousek M; Sabol M; Zapletalova J; Falt P.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma.
Tortora R; Farella N; Morisco F; Coppola C; Izzo F; Salomone Megna A; Federico A; Messina V; Nardone G; Piai G; Ragone E; Adinolfi LE; D'Adamo G; Stanzione M; Francica G; Torre P; De Girolamo V; Coppola N; Guarino M; Dallio M; Rocco L; Di Costanzo GG; Progetto Epatocarcinoma Campania Group.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhos…
Du X; Wei X; Ma L; Liu X; Guo H; Liu Y; Zhang J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver d…
Zhou Y; Tian N; Li P; He Y; Tong L; Xie W.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
High plasma soluble thrombomodulin levels indicated poor prognosis of decompensated liver cirrhosis: a prospective coho…
Wei X; Du X; Liu Y; Wu J; Zhang J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Liver cirrhosis prediction for patients with Wilson disease based on machine learning: a case-control study from southw…
Chen K; Wan Y; Mao J; Lai Y; Zhuo-Ma G; Hong P.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosy…
Bai YW; Liu JC; Yang CT; Wang YL; Wang CY; Ju SG; Zhou C; Huang SJ; Li TQ; Chen Y; Yao W; Xiong B.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The impact of hepatotoxic drugs on the outcome of patients with acute deterioration of hepatitis B virus-related chroni…
Sun J; Yu X; Weng Z; Jin L; Yang J; Zhang H; Gu J; Wang N; Yang J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
Choy AM; Lebwohl B; Krigel A.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent